Catalyze Capital (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Amsterdam
Catalyze Capital is a Dutch closed-end fund that invests in early-stage, creative firms across Europe.
Average round investment:18.03M USD
Average number per year:2.0
Distribution:
2025 (2)
Portfolio companies:
Melt&Marble
Gesynta Pharma
Melt&Marble
Gesynta Pharma
Mostly invests in:
Sweden (2)
Food Industry (1)
Sweden (2)
Food Industry (1)
2 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Catalyze Capital
| Name | Criteria | |
|---|---|---|
![]() |
Niklas Zennström
83%
|
|
![]() |
Johan Dennelind
83%
|
|
![]() |
Victor Jacobsson
83%
|
|
![]() |
Adjacent
83%
|
|
![]() |
Martin Dahlin
83%
|
|
![]() |
Amboy Street Ventures
83%
|
|
![]() |
Gullspång Invest
82%
|
|
![]() |
Ferd Capital
82%
|
|
![]() |
Flerie Invest
82%
|
|
![]() |
Ash Pournouri
82%
|
|



Belgium
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
France
Ireland
Italy
Portugal
Spain
United Kingdom